Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-818

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride, showing the molecular arrangement with labeled chemical groups including hydrocarbon and nitrogen atoms.*
FDA Label Image

Label (51655 818 53 Rev A 08 23 Nhc)

Label (51655 818 53   Rev A 08 23 Nhc)
Label for Cyclobenzaprine Hydrochloride Tablets USP 5 mg, containing 10 film-coated tablets. The label notes Rx only status, storage instructions at controlled room temperature, and warnings to keep out of reach of children and to keep the container tightly closed. The product is labeled by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.